CA1 | Carbonic anhydrase I | Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
HEMGN | Hemogen | Predicted intracellular proteins
| | | | | Group enriched |
MLC1 | Megalencephalic leukoencephalopathy with subcortical cysts 1 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
CR2 | Complement component (3d/Epstein Barr virus) receptor 2 | CD markers Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
NME8 | NME/NM23 family member 8 | Disease related genes Predicted intracellular proteins
| | | | | Group enriched |
MS4A1 | Membrane-spanning 4-domains, subfamily A, member 1 | CD markers Disease related genes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
ADD2 | Adducin 2 (beta) | Cytoskeleton related proteins Predicted intracellular proteins
| | | | | Group enriched |
GSDMC | Gasdermin C | Predicted intracellular proteins
| | | | | Group enriched |
MEF2B | Myocyte enhancer factor 2B | Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
S100A8 | S100 calcium binding protein A8 | Cancer-related genes Cytoskeleton related proteins Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
FCRLA | Fc receptor-like A | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
MCEMP1 | Mast cell-expressed membrane protein 1 | Predicted membrane proteins
| | | | | Group enriched |
CD19 | CD19 molecule | CD markers Disease related genes Predicted membrane proteins
| | | | | Group enriched |
FCER2 | Fc fragment of IgE, low affinity II, receptor for (CD23) | Cancer-related genes CD markers Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
P2RX5 | Purinergic receptor P2X, ligand-gated ion channel, 5 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
CLEC4M | C-type lectin domain family 4, member M | CD markers Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
DRD5 | Dopamine receptor D5 | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
HIST1H3A | Histone cluster 1, H3a | Predicted intracellular proteins
| | | | | Group enriched |
TNFRSF13C | Tumor necrosis factor receptor superfamily, member 13C | CD markers Disease related genes Predicted membrane proteins
| | | | | Group enriched |
CD72 | CD72 molecule | CD markers Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
BTLA | B and T lymphocyte associated | CD markers Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
CEACAM6 | Carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen) | Cancer-related genes CD markers Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
DPPA4 | Developmental pluripotency associated 4 | Predicted intracellular proteins
| | | | | Group enriched |
FCN1 | Ficolin (collagen/fibrinogen domain containing) 1 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
FDCSP | Follicular dendritic cell secreted protein | Predicted secreted proteins
| | | | | Group enriched |
LYZ | Lysozyme | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Group enriched |
SLC2A14 | Solute carrier family 2 (facilitated glucose transporter), member 14 | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
BANK1 | B-cell scaffold protein with ankyrin repeats 1 | Disease related genes Predicted intracellular proteins
| | | | | Group enriched |
CCR7 | Chemokine (C-C motif) receptor 7 | Cancer-related genes CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
CLEC4G | C-type lectin domain family 4, member G | Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
CXCR5 | Chemokine (C-X-C motif) receptor 5 | CD markers G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
KCNJ5 | Potassium inwardly-rectifying channel, subfamily J, member 5 | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Group enriched |
POU2F2 | POU class 2 homeobox 2 | Cancer-related genes Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
S100A9 | S100 calcium binding protein A9 | Cancer-related genes Cytoskeleton related proteins Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
SP140 | SP140 nuclear body protein | Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
STAB2 | Stabilin 2 | Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
VIP | Vasoactive intestinal peptide | Cancer-related genes Predicted intracellular proteins Predicted secreted proteins
| | | | | Group enriched |